Goldman Sachs’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215M Buy
1,275,806
+71,760
+6% +$12.3M 0.02% 654
2025
Q4
$203M Sell
1,204,046
-1,343,824
-53% -$218M 0.02% 633
2025
Q3
$368M Buy
2,547,870
+65,728
+3% +$8.97M 0.05% 396
2025
Q2
$314M Buy
2,482,142
+1,952,538
+369% +$240M 0.04% 417
2025
Q1
$67.7M Sell
529,604
-327,035
-38% -$44.3M 0.01% 1024
2024
Q4
$113M Sell
856,639
-510,539
-37% -$71.8M 0.02% 744
2024
Q3
$199M Sell
1,367,178
-1,786,690
-57% -$259M 0.03% 520
2024
Q2
$433M Sell
3,153,868
-58,897
-2% -$7.86M 0.07% 261
2024
Q1
$441M Buy
3,212,765
+1,033,916
+47% +$141M 0.08% 256
2023
Q4
$296M Sell
2,178,849
-242,635
-10% -$29.6M 0.05% 357
2023
Q3
$296M Buy
2,421,484
+1,311,490
+118% +$167M 0.06% 292
2023
Q2
$141M Sell
1,109,994
-719,903
-39% -$93.5M 0.03% 569
2023
Q1
$236M Sell
1,829,897
-44,216
-2% -$5.79M 0.05% 364
2022
Q4
$246M Buy
1,874,113
+559,584
+43% +$72.3M 0.06% 350
2022
Q3
$154M Sell
1,314,529
-232,348
-15% -$28.9M 0.04% 494
2022
Q2
$182M Sell
1,546,877
-21,282
-1% -$2.53M 0.05% 428
2022
Q1
$204M Buy
1,568,159
+395,420
+34% +$51.5M 0.04% 427
2021
Q4
$179M Sell
1,172,739
-1,082,636
-48% -$168M 0.04% 502
2021
Q3
$365M Buy
2,255,375
+274,579
+14% +$46.2M 0.08% 234
2021
Q2
$324M Sell
1,980,796
-1,276,873
-39% -$197M 0.07% 258
2021
Q1
$490M Sell
3,257,669
-2,916,653
-47% -$463M 0.12% 152
2020
Q4
$935M Buy
6,174,322
+2,634,039
+74% +$376M 0.24% 61
2020
Q3
$479M Sell
3,540,283
-2,903,879
-45% -$394M 0.14% 133
2020
Q2
$881M Buy
6,444,162
+2,307,039
+56% +$294M 0.27% 59
2020
Q1
$446M Sell
4,137,123
-328,674
-7% -$37.8M 0.16% 116
2019
Q4
$538M Buy
4,465,797
+1,719,995
+63% +$192M 0.14% 137
2019
Q3
$273M Buy
2,745,802
+657,081
+31% +$68.8M 0.08% 268
2019
Q2
$228M Sell
2,088,721
-1,126,863
-35% -$120M 0.07% 321
2019
Q1
$360M Buy
3,215,584
+1,696,701
+112% +$186M 0.11% 172
2018
Q4
$146M Sell
1,518,883
-602,613
-28% -$64M 0.05% 439
2018
Q3
$259M Sell
2,121,496
-1,483,044
-41% -$175M 0.07% 313
2018
Q2
$396M Buy
3,604,540
+1,519,549
+73% +$163M 0.11% 173
2018
Q1
$223M Sell
2,084,991
-625,607
-23% -$69.3M 0.06% 376
2017
Q4
$289M Sell
2,710,598
-1,300,192
-32% -$139M 0.07% 314
2017
Q3
$446M Buy
4,010,790
+816,420
+26% +$87.3M 0.11% 166
2017
Q2
$330M Sell
3,194,370
-1,839,684
-37% -$181M 0.09% 221
2017
Q1
$492M Buy
5,034,054
+1,957,380
+64% +$187M 0.13% 126
2016
Q4
$272M Sell
3,076,674
-1,810,359
-37% -$165M 0.08% 263
2016
Q3
$472M Sell
4,887,033
-204,489
-4% -$19.5M 0.14% 110
2016
Q2
$437M Sell
5,091,522
-1,494,945
-23% -$134M 0.14% 112
2016
Q1
$573M Sell
6,586,467
-1,337,598
-17% -$120M 0.19% 88
2015
Q4
$894M Sell
7,924,065
-1,434,924
-15% -$156M 0.28% 45
2015
Q3
$946M Buy
9,358,989
+1,491,075
+19% +$179M 0.32% 36
2015
Q2
$968M Sell
7,867,914
-895,356
-10% -$107M 0.3% 39
2015
Q1
$1B Buy
8,763,270
+2,529,732
+41% +$279M 0.32% 37
2014
Q4
$630M Sell
6,233,538
-5,240,910
-46% -$509M 0.2% 78
2014
Q3
$1.05B Buy
11,474,448
+1,397,829
+14% +$123M 0.33% 32
2014
Q2
$863M Buy
10,076,619
+1,030,908
+11% +$81.2M 0.27% 48
2014
Q1
$713M Buy
9,045,711
+1,981,800
+28% +$165M 0.23% 60
2013
Q4
$535M Buy
7,063,911
+2,701,164
+62% +$192M 0.18% 105
2013
Q3
$305M Sell
4,362,747
-167,991
-4% -$11M 0.11% 175
2013
Q2
$263M Buy
+4,530,738
New +$262M 0.1% 201

Other funds holding IBB